You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Encorafenib, binimetinib, pembrolizumab

Showing 1 - 25 of 1,556
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Worldwide (encorafenib, binimetinib, pembrolizumab)

Recruiting
  • Melanoma
  • Siena, Toscana, Italy
  • +11 more
Jun 23, 2023

Malignant Melanoma, BRAF V600 Mutation, Brain Metastases Trial in France (Stereotaxic radiosurgery (SRS), Binimetinib Oral

Recruiting
  • Malignant Melanoma
  • +2 more
  • Stereotaxic radiosurgery (SRS)
  • +3 more
  • Bobigny, France
  • +20 more
Oct 7, 2022

Malignant Melanoma Trial in Herlev, Aarhus, Odense (Pembrolizumab Injection [Keytruda], Ipilimumab Injection [Yervoy], Nivolumab

Recruiting
  • Malignant Melanoma
  • Pembrolizumab Injection [Keytruda]
  • +6 more
  • Herlev, Hovedstaden, Denmark
  • +2 more
Sep 16, 2022

Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

Recruiting
  • Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2022

Malignant Melanoma, Metastatic Melanoma, Immunotherapy Trial (Pembrolizumab, Encorafenib, Binimetinib)

Not yet recruiting
  • Malignant Melanoma
  • +4 more
  • (no location specified)
Mar 31, 2022

Immunotherapy Among BRAF-Positive Melanoma Patients Treated in

Completed
  • Metastatic Melanoma
  • East Hanover, New Jersey
    Novartis Investigative Site
Nov 11, 2022

Malignant Melanoma Trial in Germany (Encorafenib, Binimetinib, Pembrolizumab)

Completed
  • Malignant Melanoma
  • Freiburg, Baden-Württemberg, Germany
  • +10 more
Feb 13, 2021

ive is Encorafenib Plus Binimetinib in Real-world and Clinical

Not yet recruiting
  • Metastatic Melanoma
  • (no location specified)
Jul 12, 2023

Healthcare Resource Utilization and Costs in Metastatic Melanoma

Terminated
  • Metastatic Melanoma
    • East Hanover, New Jersey
      Novartis Investigational Site
    Apr 27, 2023

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in

    Recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 9, 2022

    Colorectal Cancer, Colon Cancer, BRAF V600E Trial (Binimetinib)

    Not yet recruiting
    • Colorectal Cancer
    • +4 more
    • (no location specified)
    Aug 18, 2022

    Solid Tumor Trial in Toronto (Binimetinib, Encorafenib)

    Recruiting
    • Solid Tumor
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Sep 23, 2022

    BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

    Recruiting
    • BRAF NP_004324.2:p.V600M
    • +6 more
    • Portland, Oregon
      Providence Portland Medical Center
    Aug 17, 2022

    Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma Trial in Leiden (Encorafenib + Binimetinib)

    Recruiting
    • Melanoma Stage III
    • In-Transit Metastasis of Cutaneous Melanoma
    • Encorafenib + Binimetinib
    • Leiden, Zuid-Holland, Netherlands
      Leiden University Medical Center
    Mar 2, 2023

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

    Terminated
    • Metastatic Colon Adenocarcinoma
    • +27 more
    • San Francisco, California
    • +1 more
    Jan 5, 2023

    Melanoma Trial in Worldwide (Encorafenib, Binimetinib, Pembrolizumab)

    Recruiting
    • Melanoma
    • Tucson, Arizona
    • +112 more
    Jul 26, 2022

    Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Brain
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation Trial in Tampa (Encorafenib Pill, Binimetinib Pill, Nivolumab)

    Recruiting
    • Melanoma Stage III
    • +2 more
    • Encorafenib Pill
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    May 27, 2022

    BRAF V600 Mutation, Unresectable Melanoma, Metastatic Melanoma Trial in Czechia, Italy, Spain (Encorafenib + Binimetinib)

    Not yet recruiting
    • BRAF V600 Mutation
    • +3 more
    • Encorafenib + Binimetinib
    • Olomouc, Czechia
    • +5 more
    Sep 14, 2021

    Melanoma Trial in Pittsburgh (encorafenib, nivolumab, ipilimumab)

    Recruiting
    • Melanoma
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Mar 24, 2022

    Cancer, Advanced Solid Tumor Trial in Kettering (lorlatinib, encorafenib + binimetinib, talazoparib)

    Recruiting
    • Cancer
    • Advanced Solid Tumor
    • Kettering, Ohio
      Kettering Health Network
    Oct 14, 2022

    Melanoma, Cancer Trial in Cambridge (Encorafenib + Binimetinib, Standard Adjuvant Treatment)

    Not yet recruiting
    • Melanoma
    • Cancer
    • Encorafenib + Binimetinib
    • Standard Adjuvant Treatment
    • Cambridge, England, United Kingdom
      Addenbrooke's Hospital
    Oct 15, 2021

    Breast Adenocarcinoma, Metastatic Triple-Negative Breast Carcinoma, Stage III Breast Cancer AJCC v7 Trial in Jacksonville (drug,

    Active, not recruiting
    • Breast Adenocarcinoma
    • +6 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Dec 14, 2021

    BRAF V600E-mutant Metastatic Colorectal Cancer Trial in Worldwide (encorafenib, Binimetinib, Cetuximab)

    Active, not recruiting
    Has Results
    • BRAF V600E-mutant Metastatic Colorectal Cancer
    • New York, New York
    • +44 more
    Aug 8, 2022

    Metastatic Melanoma, Brain Metastases Trial in Spain (encorafenib, binimetinib, Whole brain radiation therapy)

    Recruiting
    • Metastatic Melanoma
    • Brain Metastases
    • Palma De Mallorca, Baleares, Spain
    • +20 more
    Feb 16, 2022